Executive Editor Michael Roy speaks with Leah S. Richmond-Rakerd, Ph.D., about her research on the antecedents, clinical features, and life characteristics of adolescents who engage in bothself-harming and violent criminal behaviors.

Executive Editor Michael Roy speaks with Patricia J. Conrod, Ph.D., about her research on the relationship betweensubstance use and adolescent cognitive development. Deputy Editor Kathleen T. Brady, M.D., Ph.D., discusses her editorial onimproving our understanding of substance use disorders.

Ned Kalin, M.D., begins his term as Editor-in-Chief of theJournal. Speaking with Executive Editor Michael Roy, Dr. Kalinoutlines his vision for his tenure and discusses the kinds of research that will appear in theJournal.

This month, Deputy Editor Susan K. Schultz, M.D., discusses combat attachment behaviors in former service members with PTSD, postpartum psychosis, the association between pain and opioid use disorder, work productivity in relation to depression outcome, neural response to rewards as a predictor of depression, and adjustment disorder following trauma exposure.

This month, Deputy Editor Susan K. Schultz, M.D., discusses practice and policies on perinatal substance abuse, relapse risk in patients with remitted depression, right unilateral ultrabrief-pulse ECT combined with medication in acute and maintenance geriatric depression, suicide risk calculated prospectively in a population cohort, and a new approach to fear and anxiety that takes into account both behavioral responses and conscious feeling states.

This month, Deputy Editor Susan K. Schultz, M.D., discusses research on preventing firearm suicide, treatment guidelines for adult attention deficit hyperactivity disorder, long-term effects of supported employment for people with psychiatric disabilities, predicting psychosis risk in individuals with prodromal symptoms, how often psychotic experiences precede mental disorders and vice versa, and a 30-year follow-up study of offspring of depressed parents.

This month, Deputy Editor Susan K. Schultz, M.D., discusses the diagnosis and treatment of trichotillomania, combining antidepressants with antipsychotics in schizophrenia, outcomes of the FDA reduction in the citalopram maximum dosage, heritable and nonheritable pathways to early callous and unemotional behaviors, and the effect of marriage on the risk for alcohol use disorder.

This month, Deputy Editor Susan K. Schultz, M.D., discusses accelerometers in diagnosis and treatment of late-life depression, concomitant use of SSRIs and statins, treatment of cognitive impairment in schizophrenia with an alpha-7 nicotinic receptor agonist, the relation of adolescent marijuana use to subclinical psychotic symptoms and to mortality at age 60, and the effect of nicotine exposure during pregnancy to development of schizophrenia in offspring.

This month, Deputy Editor Susan K. Schultz, M.D., discusses how psychiatrists can extend their role to treatment of general health conditions, how to evaluate randomized clinical trials, interpersonal psychotherapy for mental health problems, fluidity of symptoms in borderline personality disorder, predictors of bipolar illness in offspring of bipolar parents, and the relation of prenatal maternal distress to fetal behavior and to DNA changes in glucocorticoid-related genes in the placenta.

This month, Executive Editor Michael Roy discusses nutrient-based treatments as adjuncts to antidepressants, the prevalence and characteristics of cannabis use disorder as defined in DSM-5, long-term mortality rates in women with severe postpartum psychiatric disorders, a program for children in foster care and their biological parents designed to prevent repetition of childhood maltreatment, whether the relationship between preschool poverty and school-age depression is mediated by functional brain connectivity, and the NIMH Research Domain Criteria project.

This month, Executive Editor Michael Roy discusses a generalist model for treatment of borderline personality disorder, citalopram treatment for agitated patients with Alzheimer’s dementia, buprenorphine for severe suicidal ideation and as an adjunctive treatment in cases of antidepressant nonresponse, effects of prenatal choline supplementation on early-childhood behavior problems, and mechanisms of executive system dysfunction across psychiatric disorders in youths.

This month, Deputy Editor Susan K. Schultz, M.D., discusses lurasidone for major depression with mixed features, bitemporal ECT compared with high-dose unilateral ECT given twice a week, neurocircuitry of depression with increased versus decreased appetite, attenuated psychosis syndrome, identification of distinct psychosis biotypes, and comprehensive community care for first-episode psychosis.

This month, Deputy Editor Susan K. Schultz, M.D., discusses depression following stroke, cerebral abnormalities in patients with first-episode schizophrenia, risks of poorly monitored ketamine use for depression, long-term outcomes of light therapy versus CBT for seasonal affective disorder, the reproductive safety of second-generation antipsychotics, and the effects of antipsychotic review and nonpharmacological interventions on antipsychotic use, symptoms, and mortality in nursing home residents.

This month, Executive Editor Michael Roy discusses the risk of postpartum relapse in bipolar disorder and postpartum psychosis, the relation of pregnant women’s defense mechanisms to later behavior in their toddlers, sequential integration of pharmacotherapy and psychotherapy for depression, the dose-response relationship of SSRIs, the effectiveness of clozapine versus standard antipsychotic treatment for schizophrenia, and the relation of prenatal maternal depression, SSRIs, and benzodiazepines to infant neurobehavioral functioning.

This month, Deputy Editor Susan K. Schultz, M.D., discusses a request for abortion by a woman with major depression and psychosis, prescription opioid abuse and its treatment, questions about MRI findings of neuropathology underlying psychiatric illness, predicting response to antipsychotic drugs from baseline striatal functional connectivity, the association between obesity and ADHD, and amygdala hyperactivity during autobiographical recall as a possible trait marker of depression.

This month, Deputy Editor Susan K. Schultz, M.D., discusses management of alcohol use disorder in patients requiring liver transplant, adding ziprasidone to escitalopram for treatment of depression, attention training for reducing PTSD symptoms, extended-release guanfacine for hyperactivity in autism spectrum disorder, a program for preventing anxiety disorders in offspring of anxious parents, and pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders.

This month, Deputy Editor Susan K. Schultz, M.D., discusses psychiatric symptoms in Wilson’s disease, interactions between inflammation and depression, circulating miRNA levels in schizophrenia, the relation of smoking status to later schizophrenia, development of posttraumatic stress disorder in Army service members following traumatic brain injury, and working in the Amish culture.

This month, Executive Editor Michael Roy discusses ketamine and other NMDA antagonists as treatments for depression, a gene-environment interaction affecting depression risk, a longitudinal study of ADHD in children and adults, a follow-up of adolescents at clinical high risk of psychosis, and a clinical trial of citicoline for cocaine dependence in bipolar I disorder.

This month, Deputy Editor Susan K. Schultz, M.D., discusses differential diagnosis of frontotemporal dementia, autoimmune encephalitis in postpartum psychosis, the role of oxytocin in borderline personality disorder, neural correlates of error processing in young people exposed to severe childhood abuse, light therapy versus cognitive-behavioral therapy for seasonal affective disorder, and cognitive enhancement treatment for people with mental illness who do not respond to supported employment.

This month, Deputy Editor Susan K. Schultz, M.D., discusses the role of the psychiatrist in the collaborative care model, pharmacological management of Lewy body dementia, the relationship of depression subtype to antidepressant response, amygdala activity at rest in paranoid individuals with schizophrenia, and use of clonidine in opioid abstinence to prolong abstinence and decouple stress from craving in daily life.

This month, Deputy Editor Susan K. Schultz, M.D., discusses diagnostic precursors of bipolar disorder in offspring of bipolar parents, intergenerational transmission of anxiety in the children of twins, separation anxiety disorder in children and adults, genetic and environmental influences on irritability from childhood to young adulthood, and the relation of impaired response inhibition to neural activation in adolescents with ADHD, their siblings, and healthy subjects.

This month, Executive Editor Michael Roy discusses psychiatric care during hepatitis C treatment with the new direct-acting antivirals, cognitive-behavioral therapy for anxiety disorders in adolescents, brain development over time in adolescents who are heavy drinkers, a genetic polymorphism related to early escalation of drinking and to impulsivity, how working memory is related to the ratio of serum levels of clozapine and its major metabolite, and a clinical trial testing the combination of citalopram and methylphenidate for geriatric depression.

This month, Deputy Editor Susan K. Schultz, M.D., discusses narcissistic personality disorder, interpersonal psychotherapy for PTSD, brief cognitive-behavioral therapy to reduce suicide attempts in high-risk military personnel, effects on children of their mothers’ response to antidepressant medication, and the relation of autistic traits to neuroanatomy in the general population.

This month, Deputy Editor Susan Schultz discusses an innovative study that used an algorithm to search electronic health records for clinical information relevant to the Research Domain Criteria; potentially modifiable conditions that predict a transition from mild cognitive impairment to dementia; a trial of cognitive-bias modification to reduce reactivity to alcohol cues in patients with alcohol dependence; a clinical trial that added health coaching to fitness club membership for overweight persons with serious mental illness; and an intriguing short essay about correspondence between Charles Darwin and the head gardener at an English mental institution.

This month, Executive Editor Michael Roy discusses adjustment disorder in a health care worker with Ebola, a case of psychotic symptoms that improved with a gluten-free diet, medication prescribing for first-episode schizophrenia, outcomes for young people at ultra-high risk for psychosis who do not transition to psychotic disorders, possible mechanisms in perimenopausal depression, and change during adolescence in reactivity of the amygdala in relation to stressful life events and family history of depression.

This month, Deputy Editor Susan K. Schultz, M.D., discusses treatment for postpartum psychosis and mania, a home-visiting intervention for pregnant teenage American Indian mothers, brain patterns underlying learning deficits in autism spectrum disorders, an approach to the genetics of schizophrenia focusing on clusters of genetic variants and clusters of clinical features, and effects of the Affordable Care Act’s expansion of insurance for young adults on rates of hospital admissions and emergency department visits.

This month, Deputy Editor Susan K. Schultz, M.D., discusses hypercalcemia and hyperparathyroidism during lithium therapy, a weight loss intervention tailored to individuals taking antipsychotic medications, the effect of socioeconomic disadvantage on outcome of collaborative depression care in OB-GYN clinics, ECT for treatment-resistant bipolar depression, ECT for clozapine-resistant schizophrenia, and the relation of an intervention for kindergartners with chronic conduct problems to psychopathology and crime at age 25.